Home / Publications


Reference Early stage gastric diffuse large B-cell lymphomas: results of a randomized trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. L Leuk Lymphoma. 2009 Jun; 50(6):925-31 Link
Author(s) Martinelli G, Gigli F, Calabrese L, Ferrucci PF, Zucca E, Crosta C, Pruneri G, Preda L, Piperno G, Gospodarowicz M, Cavalli F, Moreno Gomez H
Study IELSG4
Reference Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome. A study by the International Extra-nodal Lymphoma Study. Annals of Oncology 2009 Dec; 20(12):1993-9 Link
Author(s) Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, Calabrese L, Pruneri G, Santoro L, Kuper-Hommel M, Tsang R, Zinzani PL, Taghian A, Zucca E., F. Cavalli
Study IELSG15
Reference Chlorambucil versus observation after anti-helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. Br J Haematol. 2009 Feb; 144(3): 367-75 Link PDF (210K)
Author(s) Hancock BW, Qian W, Linch D, Delchier JC, Smith P, Jakupovic I, Burton C, Souhami R, Wotherspoon A, Copie-Bergman C, Capella C, Traulle C, Levy M, Cortelazzo S, Ferreri AJ, Ambrosetti A, Pinotti G, Martinelli G, Vitolo U, Cavalli F, Gisselbrecht C, Zucca E
Study IELSG3
Reference Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma. J Clin Oncol. 2008 Nov 1;26(31):5134-6; correspondence Link
Author(s) Ferreri AJ, Dognini GP, Govi S, Crocchiolo R, Bouzani M, Bollinger CR, D’Incan M, Delaporte E, Hamadani M, Jardin F, Martusewicz-Boros M, Montanari M, Szomor A, Zucca E, Cavalli F, Ponzoni M
Study IELSG7
Reference The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in ‘western’ patients with intravascular large B-cell lymphoma. Br J Haematol 2008 October; 143(2): 253-257 Link
Author(s) Ferreri AJM, Dognini GP, Bairey O, Szomor A, Montalbán C, Horvath B, Demeter J, Uziel L, Soffietti R, Seymour JF, Ambrosetti A, Willemze R, Martelli M, Rossi G, Candoni A, De Renzo A, Doglioni C, Zucca E, Cavalli F, Ponzoni M
Study IELSG17
Reference Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Annals of Oncology 2008; 19(2): 233-241 Link
Author(s) Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, Roos D, Lennard A, Devizzi L, Crabb S, Hossfeld D, Pratt G, Dell’olio M, Choo SP, Bociek RG, Radford J, Lade S, Gianni AM, Zucca E, Cavalli F, Seymour JF
Study IELSG15
Reference Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type. Hematological Oncology, 2007 Dec; 25(4):184-188 Link
Author(s) Tibiletti MG, Milani K, Martin V, Zucca E, Motta T, Cortelazzo S, Pinotti G, Mazzucchelli L, Pruneri G, Martinelli G, Barbazza R, Capella C and Bertoni F on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Study IELSG16
Reference Reactive perivascular T-cell infiltrate predicts survival in primary CNS B-cell lymphomas. Br J Haematol.2007 Aug; 138(3):316-323 Link
Author(s) Ponzoni M, Berger F, Chassagne-Clement C, Tinguely M, Jouvet A, Ferreri JM, Dell’Oro S, Terreni MR, Doglioni C, Weis J, Cerati M, Milani M, Iuzzolino P, Motta T, Carbone A, Pedrinis E, Sanchez J, Blay JY, Reni M, Conconi A, Bertoni F, Zucca E, Cavalli F and Borisch B
Study IELSG7
Reference Definition, diagnosis and management of intravascular lymphoma: proposals and perspectives from an international consensus meeting (Locarno, Switzerland; December 9-10, 2005). J Clin Oncol. 2007 Jul 20; 25(21):3168-73 Link
Author(s) Ponzoni M, Ferreri AJM, Campo E, Facchetti F, Mazzucchelli L, Yoshino T, Murase T, Pileri SA, Doglioni C, Zucca E, Cavalli F and Nakamura S
Study IELSG17
Reference Variations in clinical presentation, frequency of haemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Hematologica 2007; 92(04):486-492 Link
Author(s) Ferreri AJM, Dognini GP, Campo E, Willemze R, Seymour JF, Bairey O, Martelli M, De Renzo A, Doglioni C, Montalbán C, Tedeschi A, Pavlovsky A, Morgan S, Uziel L, Ferracci M, Ascani S, Gianelli U, Patriarca C, Facchetti F, Dalla Libera A, Pertoldi B, Horvath B, Szomor A, Zucca E, Cavalli F and Ponzoni M on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Study IELSG17
Reference Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the cutaneous variant. Br J Haematol. 2004 Oct; 127(2):173-183 Link PDF (189K)
Author(s) Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, Zucca E, Rossi G, Lopez-Guillermo A, Pavlovsky MA, Geerts ML, Candoni A, Lestani M, Asioli S, Milani M, Piris MA, Pileri S, Facchetti F, Cavalli F, Ponzoni M on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Study IELSG17
Reference Antracycline-based chemotherapy as primary treatment for intravascular lymphoma. Annals of Oncology 2004; 15(8):1215-1221 Link
Author(s) Ferreri AJM, Campo E, Ambrosetti A, Ilariucci F, Seymour JF, Willemze R, Arrigoni G, Rossi G, López-Guillermo A, Berti E, Eriksson M, Federico M, Cortelazzo S, Govi S, Frungillo N, Dell’Oro S, Lestani M, Asioli S, Pedrinis E, Ungari M, Motta T, Rossi R, Artusi T, Iuzzolino P, Zucca E, Cavalli F and Ponzoni M on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Study IELSG17